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The Postprandial Effect of Anthocyanins on Cardiovascular Disease Risk Factors:
a Systematic Literature Review of High-Fat Meal Challenge Studies
Abstract
© 2020, Springer Science+Business Media, LLC, part of Springer Nature. Purpose of review: Recurrent
post-prandial metabolic imbalances are important contributing factors to the development of
cardiovascular disease (CVD). This study evaluated whether anthocyanin consumption attenuates the
deleterious postprandial response of high-fat meals on CVD risk factors including blood pressure,
vascular endothelial function, lipid profile and biomarkers related to oxidative stress, antioxidant status
and immune response. Recent findings: Five electronic databases were searched up to the period of 1
February 2020, yielding 13 eligible studies, including randomised or cross-over clinical trials (18–59 years
of age), using PRISMA guidelines (PROSPERO registration: CRD42019126265). Potential bias was
assessed using the revised Cochrane risk-of-bias tool for randomised trials. Beneficial effects of
anthocyanins were reported in biomarkers of oxidative stress and antioxidant status in 6 out of 9 studies,
and in 3 out of 6 studies for inflammatory response. Two positive results were found concerning
attenuation of post-prandial endothelial dysfunction, increased triacylglycerol and total cholesterol
exerted by the high fat meal. Blood pressure and lipoproteins were the parameters with least beneficial
results. Summary: Our systematic literature review revealed beneficial effects of dietary anthocyanin
interventions on CVD risk factors following a HFM challenge; however, heterogeneity in results exists. The
most promising results were for the attenuation of deleterious postprandial effects on oxidative stress
and antioxidant status, triacylglycerol and total cholesterol concentrations, vascular endothelial function
and inflammatory biomarkers. Post-prandial changes in blood pressure and lipoproteins were least
affected by anthocyanins. Further studies are required in order to better elucidate the post-prandial
effects of anthocyanins and CVD risk factors.
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Abstract

27

Background & aim: Recurrent post-prandial metabolic imbalances are important contributing

28

factors to development of cardiovascular disease (CVD). The aim of this study is to evaluate

29

whether anthocyanin consumption attenuates the deleterious postprandial response of high-fat

30

meals on CVD risk factors including blood pressure, vascular endothelial function, lipid profile

31

and biomarkers related to oxidative stress, antioxidant status and immune response.

32

Methods: Five electronic databases were searched up to the period of 1st February 2020,

33

yielding 13 eligible studies, including randomised or cross-over clinical trials (18-59 years of

34

age), undertaken using the procedures outlined in the PRISMA statement (PROSPERO

35

registration: CRD42019126265). Studies were assessed for potential bias using the revised

36

Cochrane risk-of-bias tool for randomised trials

37

Results: Beneficial effects of anthocyanins were reported, in one or more biomarkers, for

38

oxidative stress and antioxidant status in 6 out of 9 studies, and in 3 out of 6 studies for

39

inflammatory response. Two positive results were found concerning attenuation of the post-

40

prandial endothelial dysfunction, increased triacylglycerol and total cholesterol exerted by the

41

high fat meal. Blood pressure and lipoproteins were the parameters with least beneficial results.

42

Conclusion: Despite some positive findings, there was heterogeneity for changes in some CVD

43

risk factors between studies. The most promising results were for the attenuation of deleterious

44

postprandial effects on oxidative stress and antioxidant status, triacylglycerol and total

45

cholesterol concentrations, as well as for vascular endothelial function and inflammatory

46

biomarkers. The post-prandial changes in blood pressure and lipoproteins were the parameters

47

least affected by anthocyanin treatment. Further studies are required in order to advance in the

48

knowledge of how post-prandial changes are associated with CVD incidence and progress, and

49

to investigate how these imbalances can be attenuated by bioactive compounds such

50

anthocyanins.
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Introduction

87

Cardiovascular diseases (CVD) are still the number one cause of death globally,

88

representing 31% of deaths in 2016. Most CVDs can be prevented by addressing and managing

89

behavioural risk factors such as diet [1]. Several CVD risk factors are associated to the

90

atherosclerotic process and other vascular dysfunctions closely linked to nutrition [2].

91

There is an emerging evidence that metabolic imbalances at the postprandial state,

92

particularly after a high-energy meal rich in fat, are important contributing factors to

93

development of CVD [3,4]. Overall, the underlying mechanism involves a sharp increase in

94

triacylglycerol along with an aberrant production of pro-oxidant molecules leading to an

95

oxidative stress state, which may impair vascular and endothelial functions, as well as mediate

96

the onset of an inflammatory response, which further contributes to the generation of more free

97

radicals, thus creating a deleterious vicious cycle [3–5]. Dietary fats comprise heterogeneous

98

molecules with diverse structures, which affect diverse cell processes such as transcription

99

regulation, cellular and organelle membrane structure and function, ion channel activity and

100

electrophysiology. Responses vary depending on both the fatty acid composition of the food

101

source, as well interactions with accompanying nutrients, the food matrix, and how it has been

102

processed[6]. Modification of the type of dietary fat in a food or overall meal has been shown

103

to result in postprandial effects on appetite [7], lipaemia and markers for inflammation and

104

endothelial activity[8].

105

The high-fat meal (HFM) challenge is one way to investigate these imbalances

106

promoted in a daily basis in Western diets [3]. Thus, this type of studies allows dietetic

107

therapeutic opportunities to attenuate the harmful effects of aberrant production of pro-oxidant

108

molecules. Nutrition plays a major role in enhancing endogenous antioxidant defences and

5
109

regulating the inflammatory state [9] and dietary components consumed alongside a high fat

110

meal may be beneficial in blunting a harmful postprandial response [10].

111

Anthocyanins, a subclass of flavonoids, are emerging as a potential therapeutic option

112

for CVD risk factors[11]. Anthocyanins are the largest class of water-soluble plant pigments,

113

that are responsible for the blue, purple and red colour of many fruits and vegetables, such as

114

blueberries, blackberries, red grapes, plums and eggplants [12]. The positive results of

115

anthocyanins on CVD risk factors are related to its antioxidant and immunomodulatory effects,

116

thereby attenuating the cooperative and synergistic deleterious effects of oxidative stress and

117

inflammation in this condition [11,12]. In humans, anthocyanins intake has been associated

118

with a lower risk of cardiovascular events [13,14], as well as studies using anthocyanins as a

119

diet intervention have shown improvements in vascular function [15] and in biomarkers related

120

to oxidative stress [16–19], antioxidant status [17,19–21], lipid profile [22–24] and

121

inflammatory response [25,26] in both long-term and acute designs.

122

To date, there has been no review of the effect of such compounds in studies using a

123

HFM challenge. In order to address this question, a systematic literature review was undertaken

124

using the procedures outlined in the PRISMA statement [27] aiming to evaluate if concomitant

125

consumption of anthocyanins with a HFM attenuates the deleterious postprandial response of

126

parameters known to be CVD risk factors, including blood pressure, vascular endothelial

127

function, lipid profile and biomarkers related to oxidative stress, antioxidant status and immune

128

response.

129
130

Methods

131
132

Search strategy

6
133

A systematic literature review was undertaken using the procedures outlined in the

134

PRISMA statement [27]. Five electronic databases were searched up to the period of 1st

135

February 2020; Medline, Scopus, CINAHL, Web of Science and PubMed. Two researchers

136

were responsible for studies selection, data extraction, quality assessment and synthesis. The

137

search strategy was carried out in accordance with the database orientations using Boolean

138

operators (OR and AND), parenthesis, quotation marks and asterisk. Quotation marks were

139

used to search for exact terms or expressions; parenthesis were used to indicate a group of

140

search terms or combine two groups of search terms enabling all possible combinations of

141

sentences; asterisks were used to search all words derived of the precedent inflected part. The

142

groups of search terms used were: "endothelium function" or "endothelium dysfunction" or

143

"laser speckle" or "laser doppler" or "flow-mediated dilatation" or FMD or LSCI or "arterial

144

stiffness" or "pulse wave velocity" or PWV or "lipid profile" or LDL or VLDL or ox-LDL or

145

"oxidative stress" or "lipid peroxidation" or "blood pressure" or cytokines or inflammation or

146

immune or inflammatory or chemokine or adhesion or malondialdehyde or isoprostanes or

147

nitrite or nitrate or ENO* "nitric oxide") AND ("postprandial" or "postprandial" or "post

148

prandial" or "meal challenge" or "challenge meal" or "test meal") AND anthocyanins. The

149

study selection, quality assessment, data extraction and synthesis were conducted by two

150

researchers independently and then reviewed by all authors. The review was registered with

151

PROSPERO (CRD42019126265).

152
153

Selection criteria

154

Selection criteria were formed using the Population Intervention Comparison Outcome

155

Study design (PICOS) format [27]. The criteria used to screen the titles and abstracts of

156

literature returned through database searching (Table 1).

157
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Table 1. PICOS (participants, interventions, comparisons, outcomes, and study design)
criteria to define the research question
Parameter

Inclusion criteria

Participants

Young adults (18-59 years of age)

Interventions

Dietary intervention with anthocyanins in whole food or purified extract

Comparators

A comparison group receiving a control intervention
CVD risk factors including blood pressure, lipid profile, vascular and

Outcomes

endothelial function, biomarkers related to inflammation, oxidative
stress and antioxidant status

Study design

Randomised or cross-over clinical trials with high fat meal challenge
for all groups.

160
161

Only articles published in English were included. Exclusion criteria: mean age of

162

participants <18 or >59 years; no nutritional information of the HFM, placebo or dietary

163

intervention; other conditions besides the HFM challenge. Reference lists of included articles

164

were screened for further studies that may have been missed in initial database search.

165
166

Data extraction

167

Two independent reviewers extracted data and cross checked results to ensure

168

consistency. The following data were extracted from each study and reported in a summary

169

table; year of publication, author(s), participant demographics, sample size, anthocyanin source

170

and dose, control used, test meal and study outcomes (Table 2). Authors were contacted if

171

further information was required.

172
173

Risk of bias assessment

174

Studies included in this review were assessed for potential bias using the revised

175

Cochrane risk-of-bias tool for randomised trials [28]. Two researchers independently reviewed

176

each study, performing evaluation across five risk-of-bias domains, with each domain rated

8
177

either low risk, high risk or some concern of bias. The prescribed algorithm was used to

178

determine domain ratings and overall risk-of-bias judgement for each study [28].

179
180

Results

181
182

Study selection

183

A total of 9135 articles returned through database searching. 1464 duplicates were

184

removed and 7671 articles were excluded during title and abstract screening (Figure 1). The

185

full-text of the remaining 29 articles were accessed and evaluated according the study selection

186

criteria. Sixteen articles were excluded as they did not meet all criteria and the remaining 13

187

studies were eligible for the review.

188
189

Characteristics of studies included in review

190

The characteristics of the 13 studies reviewed are summarised in Table 2. All studies

191

included had a cross-over design with a wash-out period ranging from 4 to 28 days, of which

192

four were double-blinded [29–32], seven were single-blinded [26,33–38] and two did not

193

present blind strategies [39,40]. The mean age of subjects involved in included studies ranged

194

from 20.2 to 50.9 years and five studies were conducted only in male subjects [29,32,33,37,40],

195

while all other recruited men and women. The majority of studies were conducted on healthy

196

individuals, except for one study on subjects with an atherosclerosis-prone phenotype [33], one

197

on subjects with obesity and insulin resistance phenotype [35] and another one with participants

198

with at least one CVD risk factor [39]. In relation to the dose of anthocyanins used in the

199

intervention, six studies used a dose <100mg [26,30,31,33,36,39] and four studies used doses

200

>100mg [29,32,37,38], while two studies used three different doses [35,40] and one study used

201

two different doses [34] within both ranges. Overall, the dose ranged from 11.2 to 1530mg of

9
202

anthocyanins. The fat content within meal challenges were <40g in four studies [26,30,34,35]

203

and >40g in nine studies [29,31–33,36–40]. Concerning fat content as % of energy, the meal

204

challenges in six studies provided >50% of energy from fats[29,30,32,33,39,40], while seven

205

studies provided <50% energy from fats[26,31,34–38]. The main type of fats within the

206

challenge meals were derived from animal products with high content of saturated fats such as

207

cream, sausages, cheese, fried potatoes, bacon, eggs and butter. There were no relevant source

208

of omega-3 fatty acids included in any of the challenge meals. All studies used a macronutrient

209

matched placebo in the control arm. In eleven studies [26,29–37,39], either a beverage, yoghurt

210
211
212

Figure 1: Flow diagram of the search and selection strategy.

10
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or smoothie was used, while two studies[38,40] provided meals without incorporating

214

the freeze-dried source of anthocyanins. One study used water as an additional control

215

treatment[39], while another also matched the content of vitamin C in the placebo[32].

216
217

Risk of bias

218

The overall risk of bias was judged as “low risk” for ten studies [26,29,30,32,34–36,38–

219

40], while three studies [31,33,37] were judged as having “some concern” due to ranking as

220

such in one or more risk domains (Table 3). Among the studies that were identified as having

221

“some concern” regarding risk of bias, two studies [33,37] had missing information on domain

222

1 (risk of bias arising from the randomization process) and one study [31] had missing

223

information on domain 3 (risk of bias due to missing outcome data) [28].

224
225

Outcomes

226

The outcomes analysed in the included studies were blood pressure, lipid profile,

227

vascular and endothelial function, as well as biomarkers related to inflammation, oxidative

228

stress and antioxidant status (Table 2). The postprandial response of such outcomes were

229

analysed after the intake of the high-fat meal challenge, which means that a significant decrease

230

may actually mean an attenuation of an increase pattern. Three studies measured blood pressure

231

[29,38,39] before and after the HFMC, none of which found significant changes in systolic

232

blood pressure. One study found a reduction in diastolic blood pressure in the anthocyanins

233

intervention group (p=0.0045), while an absence of effect was observed in the other two arms

234

administering water or a matched anthocyanins-free placebo [39]. Vascular and endothelial

235

function were evaluated by three studies [29,38,39]. Alqurashi et al. [29] assessed endothelial

236

function in the brachial artery by flow-mediated dilatation (FMD) with a postprandial increase

237

of 1.4% versus 0.4% at 2h (p=0.001) and an increase of 0.8% versus a decrease of -0.3% at 6h

11
238

Table 2. High-fat meal challenge studies analysing cardiovascular risk factors
Reference
Alqurashi et
al.
2015,
UK[29]

Population sample size
Healthy male adults
(n=23), mean age 46yr
± 1.9, BMI 27.6kg/m2
± 0.4

Test meal
Meal+beverage:
869.7
Kcal
(60.6% from fat),
58.5g fat, 74.4g
CHO, 11.4g PTN

Outcomes
Blood pressure: ↔
FMD: ↑ 1.4%, p=0.001 at 2h and ↑ 0.8%,
p<0.001 at 4h.
Plasma total oxidant capacity (peroxide
concentrations): ↓ area under the curve over 7h,
p=0.02

Red orange juice: a)Blonde orange 890 Kcal (52.6%
53.1mg anthocyanins juice; b) water
from fat), 52g fat,
25g PTN, 81g
CHO

Augmentation index (vascular stiffness): ↓
2.18 ± 19.26 to -6.11 ± 11.90, p=0.0030
Reactive hyperemia index (vascular
reactivity): ↔
Blood pressure: ↔ (diastolic blood pressure
within group:↓ p=0.0045)
TAG: ↔ (↓ within the intervention group,
p=0.0131)

Milk based beverage + Macronutrient
strawberry
powder, matched placebo
39.04mg
beverage
anthocyanins

962.3
Kcal
(28.1% from fat),
30g fat, 36g PTN,
135g CHO

hsCRP: ↓ 3.1 (SEM 0.1) vs 2.7 (SEM 0.5)
mg/L, P=0.02 at 6h
IL-6: ↓ 3.4 (SEM 0.5) vs 4.5 (SEM 0.5) pg/ml,
P<0.05 at 6h.
TNF-α: ↔
IL-1β: ↔

Miglio et al. Healhy adults (n=14), a) Fruit juice (86% mix Energy and sugar
2012,
45yr ± 9, BMI apple,
grape, matched placebo,
2
Italy[30]
26.8kg/m ± 2.2
blueberry,
66g CHO
pomegranate juices),
6.5mg anthocyanins
b) Fruit juice (63% mix
of
pineapple,
blackcurrant and plum

1344 Kcal (54.2%
from fat), 81g fat,
104g CHO, 52g
PTN, 3.1g fibre

Urinary FRAP: ↑ 35%, p<0.01
Plasma TRAP: ↑ p<0.05 at 1h, ↑ 8%, p<0.001
at 2h, ↑ p<0.01 at 4h.
Plasma FRAP: ↔
Plasma uric acid: ↓ p<0.05 at 8h
Plasma Thiols: ↓ p<0.05 at 0.5, 1, 4 and 8h, ↓
p<0.01
Ascorbic acid: ↔

Cerletti et al. Adults
(n=18:
9
2014,
females, 9 males), 36.9
Italy[39]
± 10.5yr, BMI 26.8
±4.0. At least one CVD
risk
factor
(overweight,
hypertension,
smoking, high serum
cholesterol or TG
levels
Edirisinghe
Healthy adults (n=24,
et al. 2010, 14 females, 10males)
USA[26]
BMI
29.2
±2.3,
50.9yrs ± 15

Diet intervention(s)
Açai smoothie: 150g
frozen açai pulp, 50g
banana,
155.1Kcal,
8.5g fat, 2.4g PTN,
17.2g CHO, 7.2g fibre,
493mg anthocyanins

Control arm(s)
Colour
and
macronutrient
matched smoothie

12
juices),
anthocyanins

16mg

Ono-Moore
Healthy adults (n=23,
et al. 2016, 18 females, 5 males),
USA[34]
30yr ± 3yr, BMI
21.9kg/m2 ± 0.4

Yoghurt + freeze dried
blueberry powder: a)
87.9mg anthocyanins;
b)
154.5mg
anthocyanins

Macronutrient
matched control
yoghurt:
191
Kcal, 0.6g fat,
45.1g CHO, 1.2g
PTN, 10g fibre

653 Kcal (40.0%
from fat), 29g fat,
73.6g CHO, 24g
PTN

TAG: ↔
LDL-c: ↔
HDL-c: ↔
IL-8: ↔
IL-1β: ↔
TNF-α: ↔

Park et al. Adults with obesity
2016,
and insulin resistance
USA[35]
phenotype (n=21, 16
females, 5 males),
39.8yr ± 13.8, BMI
40.2 ± 7.2
Richter et al. Healthy adults (n=30,
2017,
13 females, 17 males),
USA[38]
BMI 31 kg/m2 ± 0.5,
28yr ± 2.0

Freeze dried whole Milk based colour
strawberry powder: a) and macronutrient
42.2mg anthocyanins; matched beverage
b) 87.9mg; c) 154.5mg

967 Kcal (23.6%
from fat), 25.4g
fat, 146.2g CHO,
36.9g PTN, 12.3g
fibre

TAG: ↔
ORAC: ↔
IL-6: ↔
OxLDL-c: ↓ –3.0 ± 0.8 U/L, p<0.05

Freeze
dried Strawberry
strawberry
powder: flavoured powder
163.41mg
(added to meal)
anthocyanins (added to
meal)

1004Kcal (44.8%
from fat), 50g fat,
105g CHO, 32g
PTN, 7g fibre

Blood pressure: ↔
TAG: ↔
OxLDL-c: ↔
MDA: ↔
Augmentation index: ↔
Aortic stiffness (PWV): ↔

Urquiaga et Healthy adult males
al.
2016, (n=9), 20.2yr (18.7Chile[40]
27.3), BMI 24.6 kg/m2
(20.7-29.4)

Berry concentrate: a) Plain burger and 527 Kcal (58.9%
added on beverage, water
from fat), 48.7g
90mg anthocyanins;
PTN, 34.33g fat,
b) added on burger and
4.6g CHO
on beverage, 174.3mg
anthocyanins

TAG: ↔
MDA: ↓ p<0.05 at all time points for
intervention “b” and ↓ p<0.05 at 5 and 6h for
intervention “a”
PTNcarbonyls: ↓ p<0.05 at 2, 3, 4, 5 and 6h
for intervention “b” and ↓ p<0.05 at 4 and 6h
for intervention “a”
Plasma FRAP: ↔
Ascorbic acid: ↔

13
Huang 2016, Healthy adults (n= 14,
USA[36]
9 males and 5 females),
25yrs ± 4, BMI
26kg/m2 ± 2

Freeze
dried
strawberry added to a
beverage,
49.02mg
anthocyanins

Macronutrients
841 Kcal (43.9% TAG: ↔
matched
from fat), 41g fat, OxLDL-c: ↔
beverage: 41Kcal, 96g CHO
IL-6: ↓ p=0.048 (intervention consumed before
0.8g PTN, 0.1g
the meal) over 10h; ↔ (intervention consumed
fat, 9.1g CHO
within and after the meal, trend p<0.1) over 10h

Kay & Holub Healhy
males(n=8), Freeze dried wild2002,
mean age 46.9 ±1.9), blueberry supplement:
Canada[37]
BMI 23.8kg/m2 ± 0.8
1160mg
anthocyanins

Control
853 Kcal (49.3%
supplement
from fat), 46.7 g
matched in CHO fat, 75.2g CHO,
and energy
32.4g PTN, 4.5g
fibre

ORAC: ↑ p<0.05
Total antioxidant status: ↑ 4.5%, p=0.05.
TAG: ↔
TC: ↔
LDL-c: ↔
HDL-c: ↔

Peluso et al. Healthy adults, (n=14,
2011,
12 males and 2
Italy[31]
females), 45.1yrs ±
8.6, BMI 26.8 kg/m2 ±
2.2

Blackcurrant,
plum
and
pineapple
beverage:
16mg
anthocyanins

Placebo beverage
devoid
of
antioxidant
activity

Meal+beverage:
1344 Kcal (30.0%
from fat), 184g
CHO, 44.8g fat,
49g PTN

TAG: ↔
TC: ↔ [prevented a significant increase
(p<0.001) observed only at the control group
over 8h]
IL-17: ↓ p<0.05 at 4 and p<0.01 at 8h
IL-6: ↓ 0.5h (p<0.01), 1h (P<0.05) and 2h
(p<0.001)
TNF-a: ↓ at multiple time points (p<0.01 at 1h,
p<0.05 at 2 and 6h, p<0.001 at 4 and 8h)

Huebbe et al. Adult
with
2011,
atherosclerosis prone
Germany[33] phenotype (n=11), 37.4
yrs ±1.9, BMI 32.1
±1.2

Blackcurrant
based
beverage
(15%
blackcurrant puree, 9%
raspberry puree, 7%
cherry puree, 39% red
grape juice + banana
puree):
11.2mg
anthocyanins (7.5mg
delphinidin-3glucoside,
7.5mg
cyanidin-3-glucoside,

Macronutrient
matched
beverage:
1029Kcal, 63.8g
fat, 6.0g PTN,
107.6g CHO, 1.8g
fibre

Blackcurrant
based beverage
(added cream and
sugar): 1029 Kcal
(55.8% from fat),
63.8g fat, 6.0g
PTN,
107.6g
CHO, 1.8g fibre

TAG: ↔ (↓ trend, p=0.059)
LDL-c: ↔
HDL-c: ↔
TC: ↔
OxLDL-c: ↔
IL-1β: ↔
TNF-α: ↔
ORAC: ↑ p<0.040 at 90min and p<0.02 at 120
min
Ascorbic acid: ↑ 14 mmol/l, p<0.004

14
0.8mg
malvidin-3glucoside)

Polley et al. Healthy adults (22 yrs Montmorency
tart
2019,
± 3.0), BMI 25.5 ±3.4 cherry
concentrate:
USA[32]
1513.8mg
anthocyanins

239
240
241
242
243
244
245
246
247
248
249

Macronutrient
matched beverage
+11mg of vitamin
C: 166.5Kcal,
CHO 39.4g; PTN
2.24g

Biscuit, sausage ORAC: ↔
patty and butter: FRAP: ↔
920 Kcal (58.7% TG: ↔
from fat), 60.0g
fat, 22.2g PTN,
72g CHO,

Abbreviations and symbols: CHO, carbohydrate; PTN, protein; FMD, flow-mediated dilatation; Kcal, kilocalories; TAG, triacylglycerol; TC, total cholesterol;
HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; OxLDL-c, oxidized low-density lipoprotein cholesterol; hsCRP, high
sensitivity C-reactive protein; FRAP, ferric reducing ability of plasma; TRAP, total radical-trapping antioxidant parameter; ORAC: oxygen radical absorbance
capacity; ↔, no significant changes; ↑, significant increase; ↓, significant decrease
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(p<0.001), comparing the intervention with the placebo group, respectively. Cerletti et al. [39]
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assessed vascular stiffness through the augmentation index (AI) and vascular reactivity through
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the reactive hyperemia index (RHI). The latter did not present significant changes, but there
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was a significant decrease (2.18 ± 19.26 to -6.11 ±11.90, p=0.0030) in the AI 3h after the meal

254

only in the anthocyanins intervention arm [39]. Richter et al. [38] investigated AI and

255

augmentation pressure through pulse wave analysis and the aortic stiffness assessed by carotid-

256

femoral pulse wave velocity (PWV). None of the parameters were significantly different

257

between intervention and control arms [38].

258

Regarding the lipid profile, ten studies evaluated triacylglycerol (TAG) [31–40], of which one

259

study found a higher decrease (p=0.0131) in the intervention group [39] and other study found

260

a trend(p=0.059) of a decrease 60 minutes after ingestion of the HFMC [33]. Total cholesterol

261

(TC) was evaluated by five studies [31,33,34,37,39] and two studies found significant changes.

262

Cerltetti et al. [39] found a reduction (p=0.0339) only in the anthocyanin intervention arm [39],

263

while Peluso et al. [31] found that the anthocyanins prevented an increase in the intervention

264

group, therefore a significant increase was only observed in the control group over 8h

265

(p<0.001) [31]. The studies that measured HDL-c [33,34,37] and LDL-c [33,34,37] did not

266

find any significant changes.

267

Among

inflammatory

markers,

six

studies

evaluated

IL-6

[26,31,33–36]

268

concentrations, of which three [26,31,36] reported significant changes. In one study [26] the

269

anthocyanin intervention was able to attenuate an increase in IL-6 response six hours after the

270

HFMC compared to the placebo group [3.4 (SEM 0.5) versus 4.5 (SEM 0.5) pg/ml, P<0.05].

271

Similarly, Peluso et al. [31] found a significant attenuation in postprandial IL-6 concentration

272

at 0.5 (p<0.01), 1 (P<0.05) and 2h (p<0.001) time points [31]. Another study [36] found a trend

273

to attenuate such response in two groups (consuming the anthocyanins intervention within or

274

after the HFMC) and a significant decrease in the group consuming the anthocyanins
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Domain 1: Risk of bias arising from the
randomisation process
Domain 2: Risk of bias due to
deviations from the intended
interventions (effect of assignment to
intervention)
Domain 3: Risk of bias due to missing
outcome data
Domain 4: Risk of bias in
measurement of the outcome
Domain 5: Risk of bias in selection of
the reported result
Overall risk of bias
276

Symbols:

low risk;

some concern

Polley et al., 2019

Huebbe et al., 2016

Peluso et al. 2011

Kay & Holub, 2002

Huang et al., 2016

Urquiaga et al, 2017

Richter et al., 2017

Park et al., 2016

Ono-Moore et al., 2016

Miglio et al., 2014

Edirisinghe et al., 2011

Cerletti et al., 2016

Table 3 – Overall risk of bias of included studies

Alqurashi et al, 2016
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intervention before the meal (p=0.048). The cytokine TNF-α was evaluated by four studies
[26,31,33,34] and with one study [31] finding a significant result preventing a postprandial rise
of TNF-α concentrations at multiple time points (p<0.01 at 1h, p<0.05 at 2 and 6h, p<0.001 at
4 and 8h).
There were no significant changes in IL-1β concentrations between treatments cross
the three studies evaluated this cytokine [26,33,34]. Only one study [26] evaluated hsCRP
concentrations before and after the HFMC presenting a significant lower concentration
compared to placebo [3.1 (SEM 0.1) versus 2.7 (SEM 0.5) mg/L, P=0.02]. Still, there was one
study that measured IL-8 concentration finding not significant results [34] and one study that
evaluate Il-17 which found a significant postprandial reduction at 4(p<0.05) and 8h(p<0.001)
time points [31].
A large variety of oxidative stress and antioxidant status biomarkers were measured by
nine studies [29,30,32,33,35–38,40] included in this review. Four studies [33,35,36,38]
evaluated OxLDL-c concentrations; however, only one study [35] found a significant reduction
(–3.0 ± 0.8 U/L, p<0.05) in the intervention arm compared to placebo. Plasma malondialdehyde
(MDA) concentration was measured in two studies [38,40] in which one found that the
anthocyanins interventions arms were able to prevent postprandial MDA accumulation (p<0.05
at multiple time points), and the mean value of the area under the curve of was reduced
compared to placebo [40]. This same study also found a reduction (p<0.05 at multiple time
points for both anthocyanins interventions) in plasma protein carbonyls and an increase in the
DPPH (2,2-diphenyl-1-picrylhydrazyl) plasma antioxidant capacity [40]. The ferric reducing
ability of plasma (FRAP) assay was used to examine antioxidant capacity in was evaluated by
three studies [30,32,40], but no significant effects of anthocyanin intervention were detected.
However, Miglio et al. [30] found a 35% increase in the urinary excretion of antioxidants as
indicated by raised urinary FRAP (P<0.01). This same study found an increase (p<0.05 at 1h,
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p<0.001 at 2h and p<0.01 at 4h) in plasma total radical-trapping antioxidant parameter (TRAP),
as well as a significant attenuation in the increase of endogenous antioxidants thiols and uric
acid (UA) (p<0.05 at 8h). Plasma ascorbic acid (vitamin C) was measured in four studies
[30,33,37,40], of which one study [33] found an increase in the anthocyanin intervention arm
(+14 mmol/l, p<0.004) compared to the placebo. The oxygen radical absorbance capacity
(ORAC) of plasma/serum was evaluated, before and after the HFMC, in five studies
[32,33,35,37,40], of which two found significant changes. In one study [33], the intervention
was able to prevent the postprandial decrease in the ORAC of plasma at 90 and 120 min
following the HFM challenge (p<0.040 and p<0.02, respectively), while another study [37]
found a significant increase in serum ORAC 1h after the HFMC in intervention group when
compared to the control (p<0.05). Furthermore, this same study found a significant increase in
the total antioxidant status (TAS) assay (+4.5%, p=0.05). Lastly, one study [29] measured the
total oxidant capacity in plasma by assessing the total peroxide concentrations, and found a
significantly lower incremental area under the curve in the intervention group(p = 0.02).

Discussion
The results of studies included in this systematic literature review indicate that the
postprandial state, after exposure to a high fat meal, may provide a useful context to investigate
acute metabolic changes, from well known lipid responses to complex phenolic compound
signalling pathways, that contribute to the development of CVD. A wide range of risk factors
such as blood pressure, lipid profile, vascular and endothelial function, as well as biomarkers
related to inflammation, oxidative stress and antioxidant status were included as outcomes in
the acute studies in the review.
Despite the lack of positive results in blood pressure, of which only study found a
significant decrease in diastolic blood pressure [39], vascular and endothelial parameters
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showed more positive results. It is more likely that such parameters will respond in a higher
magnitude than blood pressure in acute studies, due to the excess postprandial production of
pro-oxidant molecules following the HFMC. This may in turn inactivate endothelial dependent
factors, in particular nitric oxide, leading to impaired vasodilation and the onset of an
inflammatory response, which further leads to the generation of more free radicals [10,41]. In
this matter, açai consumption was associated with improvements in endothelial vascular
function, measured by FMD, in healthy overweight man, which was also followed by an
increase in total oxidant capacity in plasma, assessed as a measure of total peroxide
concentrations [29]. The significant improvement in FMD found in this study[29] was 1%
higher than in controls, a magnitude of effect that has been shown in a meta-analysis to be
associated with an overall 8 % reduction in CVD risk (RR= 0.92; 95%CI: 0.88; 0.95) for each
percentage increase [42] . Flow-mediated dilatation is a non-invasive measurement of
endothelium function that has been associated with CVD risk prediction[42,43]. Another study
found a decrease in arterial stiffness, measured by AI, after consumption of blood orange juice
anthocyanins in individual with at least one CVD risk factor (overweight, hypertension,
smoking, high serum cholesterol or triacylglycerol levels) [39].
A recent systematic review evaluated the postprandial inflammatory response to HFM
challenge, in which IL-6 was stated as the inflammatory marker with the stronger response to
this stress [44]. IL-6 has a pleiotropic nature showing both anti and pro-inflammatory roles and
regulating a plethora of immune and metabolic responses, however a high concentration of this
cytokine has been associated with CVD and mortality [45,46]. Still, IL-6 has a high expression
on vascular endothelium and the pharmacological inhibition of IL-6 improves endothelial
function [47]. The inhibitory effect on postprandial IL-6 concentrations found within the
studies added in this review demonstrates a potential therapeutic effect of anthocyanins for
CVD [26,31,36]. One possible mechanism that anthocyanins may exert this effect is through
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decreasing the activity of the NF-κB pathway, which is a transcription factor responsible for
triggering and regulating inflammatory processes, leading to the expression of proinflammatory cytokines and enzymes [11,48]. Concerning the clinical significance of the
magnitude of effects reported in the studies that observed benefits associated with anthocyanin
intake, the significant changes of between 0.34 and 0.90 pg/mL represent changes from
baseline of >2 SD[26,36] and >3 SD[31]. These results are clinically meaningful considering
the predictive roles of IL-6 concentration in CVD risk. Hazard ratios of 1.80 are reported
according to each 1-SD increase in IL-6 for risk of first-ever cerebrovascular events in
individuals with vascular risk factors without any pre-existing cardiovascular disease[49].
Further, a positive predictive value of 100% is reported for coronary artery disease when IL-6
concentrations exceed 1.0 pg/mL in patients who have an intermediate cardiovascular risk
profile and chest pain[50]. In a meta-analysis of 17 prospective studies investigating clinical
coronary outcomes (i.e., myocardial infarction or coronary death), an odds ratio of 1.61 (95%
CI 1.42–1.83) was found per 2 SD increase in baseline IL-6 [51]. Another meta-analysis of 17
studies comprising 288,738 healthy individuals reported a significantly higher IL-6
concentration in CVD cases compared to non-CVD controls (standardized mean difference
[95% CI]) of 0.14 [0.09, 0.20]/mean difference of 0.36 [0.28, 0.44] pg/mL) [52]. These
significant changes in IL-6 concentration were found only in studies which the mean BMI of
participants were >25kg/m2. Overweight and obesity are an independent risk factor for CVD,
as well as are associated with a low-grade continuous inflammation with high implications in
the atherosclerotic process. The possibility of regulating this persistent not resolved
inflammatory state can be crucial in attenuating the progress of the atherosclerosis disease,
especially in the early stages. This is the same scenario, in which the only study [26] that
evaluated CRP found a significant reduction of 0.4 (SD 0.1) mg/L in a study population with a
mean BMI >29kg/m2. This effect reduced the hsCRP concentration in the intervention arm to
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values <3.0 mg/L, which is considered a clinical threshold for many cardiovascular conditions,
including a reduced hospitalisation rate for heart failure in subjects with stable coronary heart
disease[53]. CRP is also associated with CVD and mortality [54,55], and has been implicated
in endothelial dysfunction in in vitro and in vivo studies [56,57]. On the other hand, the
cytokines IL-1β and TNF-α not appear to transiently and/or robustly change in the postprandial
period after a HFMC, thus a decrease in concentration of these molecules is not likely to occur
with acute diet interventions [44]. In the present review, the three studies that evaluate IL-1β
were conducted in healthy normal weight [34], healthy overweight [26] and overweight/obese
adults with atherosclerosis prone phenotype [33], however none of them found significant
changes. TNF-α also plays a pleiotropic and major role in CVD, but high concentrations have
been associated with deleterious effects mainly through vascular dysfunction and atherogenesis
by many mechanisms such as regulation of the vascular permeability, disruption of the
endothelial barrier, degradation of glycocalyx, increased production of ROS and decreasing
NO bioavailability and increase its removal [58,59]. In line with the review by Emerson et al.
(2017) [44], the studies included in our review found inconsistent changes of TNF-α
concentrations after the HFMC, i.e. two studies found a decrease [33,34], one an increase [31]
and other study reported no changes [26]. The study that had a postprandial increase in TNF-α
concentration was the only one that found a significant lowering effect with the diet
intervention with anthocyanins [31]. Another relevant finding in this same study was the
inhibitory effect of on postprandial increase of IL-17, a cytokine with highly pro-inflammatory
properties that are also associated with CVD, especially with cardiovascular events such as
stroke and myocardial infarction [60]. There is accumulating evidence that IL-17 it is involved
in the pathogenesis of cardiovascular diseases by amplifying the inflammation induced by other
cytokines in synergistic interactions [61]. This cytokine is also positively correlated with
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OxLDL-c, a molecule with a crucial role in the oxidative stress mediated atherosclerosis
development.
OxLDL-c is a key factor in the initiation and progression of atherosclerosis and
contributes to endothelial dysfunction and plaque destabilization through various mechanisms
[62]. Among the four studies that measured postprandial concentration of Ox-LDL-c, the only
study that found a significant reduction was conducted in participants with an obese and insulin
resistant phenotype [35]. Several other oxidative stress and antioxidant status biomarkers were
investigated within the added studies in this review, showing the most promising results in
relation to the effects of anthocyanin intervention on parameters following the HFM challenge.
MDA is an end product of lipid peroxidation, the radical-initiated oxidative decomposition of
poly-unsaturated fatty acids [63]. Urquiaga et al. [40] found a reduction in postprandial
concentration of MDA at multiple time points following two different anthocyanin
interventions (i.e. added to food or beverage) using a berry concentrate. This same study also
found a reduction in plasma protein carbonyls and an increase in the DPPH (2,2-diphenyl-1picrylhydrazyl) plasma antioxidant capacity [40]. Protein carbonylation is one of the most
harmful irreversible oxidative protein modifications, and is considered a major hallmark of
oxidative stress‐related disorders [64]. The DPPH assay is a method that is widely used to test
the ability of compounds to act as free radical scavengers or hydrogen donors, and therefore
can be used to evaluate antioxidant activity. Another anti-oxidant assay, the FRAP, (based on
single electron transfer reaction to evaluate the antioxidant effect of nonenzymatic defense in
biological fluids) was measured in three studies that reported no significant effect of the
anthocyanin intervention in plasma [30,32,40]. However, one of these studies found a 35%
increase in the urinary excretion of antioxidants (P<0.01), which was followed by an increase
TRAP and an attenuation in the increase of endogenous antioxidants thiols and UA. TRAP
differs from FRAP as an assay that measures the ability of antioxidants to buffer a reaction

23

probe against peroxidation, and it’s determined by measuring the length of time that oxygen
uptake is inhibited [65]. Results from both FRAP and TRAP methods have to be carefully
interpreted considering that FRAP has low specificity in measuring the antioxidant activity of
many important antioxidants such as ascorbic acid, glutathione and albumin, and that TRAP
does not necessarily provide a reliable or sensitive measure of the ability of plasma to interfere
with lipid peroxidation[66]. UA levels are related to oxidative status, especially antioxidant
capacity and it is well known that high plasma UA levels are strongly associated CVD [67].
Taken together, the positive results of these three different oxidative stress biomarkers show a
relevant anti-oxidant signalling effect of anthocyanins in these studies conducted in healthy
adults [30,40]. Another relevant biomarker of antioxidant status is vitamin C, which is a readily
water-soluble and not storable in tissues. Therefore, vitamin C is a good biomarker for shortterm studies [68]. One study added in this review found an increase in plasma vitamin C [33];
however, even though the placebo was matched in macronutrients and energy, only the diet
intervention had a relevant content of vitamin C (122.3 vs 0.3mg). Thus, it is unlikely that the
plasma concentration of vitamin C was increased due to the anthocyanins. The ORAC of
plasma/serum, which was evaluated in five studies in this review, appears to be a controversial
method in regard to its application for in vivo studies, especially after the withdraw of the
ORAC food database by the USDA in 2010. There is still debate regarding the absorbance and
breakdown of polyphenols, such as flavonoids and subclasses, into smaller phenolics
compounds with signalling, anti-inflammatory and anti-oxidant properties [41]. Nevertheless,
two studies found an increase in plasma ORAC following 60 [33], 90 and 120 [37] minutes
after the HFMC, and one study also found a significant increase in TAS [37], another nonspecific assay that assess the overall antioxidant status of a sample.
The post-prandial response in the lipid profile, when compared to fasting lipids, can
represent a different and even independent risk factor for CVD [4,23]. The transient lipid and
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lipoprotein accumulation that occurs in the circulation after a high-fat meal represents the
individual capacity to metabolize an acute fat input [69] and has been associated as an
important risk factor in atherosclerosis development [5]. The most relevant postprandial lipid
marker it is triacylglycerol. It is the lipid with the greatest post-prandial difference from fasting
lipid markers [23], and has been associated as an independent risk factor for cardiovascular
events [24]. The results found in our review support these statements, as significant changes
were only found in triacylglycerol [33,39] concentrations and total cholesterol [31,39], which
has a composition of 20% triacylglycerol in its formula.
The choice of placebo in this type of acute study design is important in order to identify
whether it is indeed the anthocyanin effect that is observed in the results, or whether there are
other nutrients or food constituents that may be affecting the study outcomes. All studies
included in this review included a placebo that was matched in macronutrient and fibre content,
however other nutrients such as vitamin C and other flavonoids that may also play a role in
postprandial oxidative stress and inflammation are not commonly considered. It is complex,
and often impossible, to provide a perfectly matched placebo in food studies of this type,
therefore results from studies that use different placebos should be carefully scrutinized.
The most notable challenge and limitation of this study was to address a wide range of
CVDs biomarkers assessed in this type of acute clinical trial. Overall, the comparison among
studies had a relevant clinical importance of these metabolic, immune and physiological factors
that has a synergistic impact on CVDs, however there was a variety of parameters addressed
with different methods within each of such factors. This made the possibility of meta-analysis
or other pooled analyses unfeasible, however it not impeded results to be compared narratively.
Another source of heterogeneity in these studies may have resulted from variability in the HMF
challenges regarding their macronutrient and energy content, particularly the types of fat, as
well as the format in which the meals were delivered. Accumulating evidence suggests that the
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health effects of dietary fats vary[6]. Substitution of saturated fatty acids from butterfat with
omega-6 PUFA resulted in a decreased postprandial lipaemia, as well as reduced
concentrations of IL-6, TNF-α, soluble TNF-α receptors, and soluble vascular cell adhesion
molecule-1 in overweight men[8]. However, all studies included in this review used animal
products as the main source of fat, and there were two main types of meals: 1) beverages that
were enriched with cream and/or milk; or 2) mixed meals including animal products with a
high content of saturated fat such as sausages, cheese, butter, eggs and bacon. A standardized
meal for these type of studies would be preferred but may be difficult to implement because of
cultural diversity in cuisine and dietary patterns. Despite that all included studies were
conducted in older adults (mean age ranging from 20.2 to 46.9y), there were slightly differences
in mean BMI with two studies having participants with BMI<25kg/m2 [34,40] six with BMI
from 25-30kg/m2 [26,29–31,36,39] and three with BMI>30kg/m2 [33,35,38] .Only three studies
were not conducted in healthy adults, of which participants were not considered healthy due to
lipidaemia [33], insulin-resistance phenotype [35] or with at least one CVD risk factor [39].
However, studies conducted in participants with major chronic diseases with implication on
CVDs, such as diabetes and hypertension, were not included in this review. Another feature in
the design of this type of study is that tests are conducted over multiple time following the
HFM challenge, thereby raising a concern that the number of false positive findings may be
inflated. For this reason, the interpretation of results found in only one or a few time points,
and that are not sustained, has to be interpreted with caution. Still, parameters that have been
used in the studies to investigate oxidative stress and antioxidant status represent a wide range
of analytical methods, and there is no formal mechanism to establish consensus regarding the
optimal biomarkers for such nutritional studies [68,70].

Conclusion
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Despite some positive findings, there was heterogeneity for changes in some CVD risk
factors between studies. The most promising results were for the attenuation of deleterious
postprandial effects on oxidative stress and antioxidant status, triacylglycerol and total
cholesterol concentrations, as well as for vascular endothelial function and inflammatory
biomarkers. The post-prandial changes in blood pressure and lipoproteins were the parameters
least affected by anthocyanin treatment. Further studies are required in order to advance in the
knowledge of how post-prandial changes are associated with CVD incidence and progress, and
to investigate how these imbalances can be attenuated by bioactive compounds such
anthocyanins.
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